Opioid pharmacotherapy: barriers to treatment

Angelo Pricolo examines the main reasons patients cease, or don't access, therapies for opioid dependence... and why many pharmacies don't offer it We know that about 50,000 people in Australia currently receive either methadone or buprenorphine to treat their opioid dependence. We estimate that as many as that figure again could potentially be candidates for